Publication | Closed Access

Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome

InflammationThrombosisCardiovascular DiseaseImmunologyTissue InhibitorAcute Coronary SyndromeCardiologyVascular BiologyMatrix Metalloproteinase-9Acute Myocardial InfarctionMedicineAtherosclerosisCoronary Artery DiseaseCoronary Heart DiseaseMyocardial Infarction